Basket Updated
0
Items added
The extra band(s) around 24 kDa using our Phospho-Histone H2A.X (Ser139) (20E3) Rabbit mAb #9718 are most likely mono-ubiquitylated H2AX. H2AX, like H2A, is mono-ubiquitylated.
Cell Signaling Technology® products are prevalent in CiteAb's Top Antibodies of 2022 with 9 of the top 10 most cited primary antibodies from CST.
When it comes to mouse tissue samples, not all loading control proteins are expressed equally. Learn which control is right for your research.
May 2012, Discovery platform is developed for antigen-specific monoclonal antibodies named NG-XMT(TM).
Concerns About Shellfish Growth Causes Local Nonprofits and Private Industry to Team Up to Test Rivers for CO2 Levels
Cell Signaling Technology, Inc. Announces License in Personalized Cancer Diagnostics.
Get information on ordering or contacting Cell Signaling Technology. CST is happy to answer your questions. Select the team you need to contact.
Cell viability assays measure the population of live, viable cells within a sample. Typically, viability assays measure markers of cell health, including cellular metabolism, ATP levels, and cell proliferation.
Cell Signaling Technology (CST) Enters Agreement with Roche for CDx Development
CiteAb Names Cell Signaling Technology, "Antibody Company of the Year" and "Researchers’ Choice"
Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, was honored with the 2017 CiteAb Award for &quoPTM Antibody Company of the Year" and for a third year in a row with the award for "Researchers’ Choice."
Lieping Chen, Yale University Cancer Center, Awarded Cell Signaling Technology Innovation and Translational Research Award for Outstanding Scientists of Chinese Heritage
Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal
Histone modification antibodies are validated using a peptide array assay at CST
CiteAb Names Cell Signaling Technology "Antibody Company of the Year" and "Antibody Company Succeeding in Cancer Biology"
Cell Signaling Technology Expands in China
Cell Signaling Technology Chief Scientific Officer, Dr. Roby Polakiewicz, to Speak on Two Panels at the Global Biological Standards Institute (GBSI) Antibody Validation Workshop
July 2009, BIOKÉ B.V., established in the Netherlands, is now Cell Signaling Technology Europe, B.V. and is CST’s base of operations in Europe. CST Europe is a wholly owned subsidiary of CST, Inc.
March 2011, Ventana Medical Systems, granted a worldwide non-exclusive license to CST patent rights and proprietary antibody reagents relating to the detection of epidermal growth factor receptor (EGFR) mutations for the field of tissue-based in vitro diagnostic testing.
2008 CST established a wholly owned subsidiary in Japan.
Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, was honored with the 2017 CiteAb Award for “PTM Antibody Company of the Year” and for a third year in a row with the award for “Researchers’ Choice.”
Cell Signaling Technology becomes 1% for the Planet Lighthouse Member
Cell Signaling Technology (CST), a worldwide provider of antibodies, participated in the 2016 Global Biological Standards Institute (GBSI) Antibody Validation: Standards, Policies and Practices Workshop
